Sign up to CN e-news and more >>

Elecare, A New Standard of Amino Acid-based Formula

Abbott is delighted to announce an addition to our trusted portfolio of food for special medical purposes for infants (iFSMPs), EleCare, by Similac. EleCare is the first amino acid-based formula in the UK containing synthesised 2’-fucosyllactose (2’-FL) human milk oligosaccharide (HMO). EleCare helps support the systemic immune system, as 2’-FL HMO has proven benefits on the gut and beyond† 1, 2

Breast milk is the gold standard providing not only nutrition, but protection and support for the developing immune system,3-5 which is critical, particularly in the first year of life.6 However, not every infant with allergies can be breastfed and a number of families depend on hypoallergenic formula.

HMOs are a diverse group of bioactive, non-digestible carbohydrates and the third most abundant solid component of breast milk.7, 8 Breast milk contains many distinct HMOs, which have a positive effect on gut microbiota and play an important role systemically in supporting the developing immune system.7-10

Following 18 years of extensive research into HMOs, Abbott know that 2’-FL HMO is the most abundant HMO in most mother’s milk, and we are delighted to be the first and only medical nutrition company in the UK to add 2’-FL HMO to an amino acid-based formula.

With EleCare you can:

  • Help support the immune system in the gut and beyond. 1, 2, 11
  • Support healthy growth and symptom resolution‡ 12-14
  • With a formula that is trusted by mums and healthcare professionals.15-17

IMPORTANT NOTICE: Breastfeeding is best for infants and is recommended for as long as possible during infancy.

For more information, please visit: https://nutrition.abbott/uk/product/elecare

References: 1. Reverri EJ, et al. Nutrients. 2018;10(10). pii: E1346. 2. Marriage BJ, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):649–658. 3.Kainonen E, et al. Immunological programming by breast milk creates an anti-inflammatory cytokine milieu in breast-fed infants compared to formula-fed infants. Brit J Nutrition 2013;109(11):1962–1970. 4. Walker A. Breast milk as the gold standard for protective nutrients. J Pediatr 2010;156(Suppl 2):S3–S7. 5. Lessen R, Kavanagh K. Position of the academy of nutrition and dietetics: promoting and supporting breastfeeding. J Acad Nutr Diet 2015;115(3):444–449. 6. Simon AK, et al. Proc Biol Sci 2015;282(1821): 20143085. 7. Triantis V, et al. Immunological Effects of Human Milk Oligosaccharides. Front Pediatr 2018;6:190. 8. Castanys-Munoz E, et al. Building a Beneficial Microbiome from Birth. Adv Nutr 2016;7(2):323–330. 9. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012;22(9):1147–1162. 10. Stepans MB, et al. Early consumption of human milk oligosaccharides is inversely related to subsequent risk of respiratory and enteric disease in infants. Breastfeed Med 2006;1(4):207–215. 11. Goehring KC, et al. J Nutr. 2016;146(12):2559–2566. 12. Sicherer SH, et al. J Pediatr. 2001;138:688 -693. 13. Borschel MW, et al. Clin Pediatr (Phila). 2013;52(10):910–917. 14. Borschel MW, et al. BMC Pediatr. 2014;14:136. 15. RTI research. Abbott Elecare No.1 Dr Recommended. Final Results. 2019. [PowerPoint presentation]. 16. Abbott. EleCare Promotional Claims Parent Survey. 2019

†Data collected from healthy-term infants fed standard infant formula (Similac) with 2’-FL HMO, compared to control formula without

‡Data collected from infants fed standard EleCare formula without 2’-FL HMO.

Date of preparation: February | ANUKANI200054

Latest news

Archives

Copyright © 2020 Nutrition2Me. All Rights Reserved | Privacy policy >>